Paul C. Grint
2015 - Regulus Therapeutics
In 2015, Paul C. Grint earned a total compensation of $5M as President & Chief Executive Officer at Regulus Therapeutics, a 95% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $250,000 |
|---|---|
| Option Awards | $4,306,175 |
| Salary | $446,532 |
| Other | $4,022 |
| Total | $5,006,729 |
Grint received $4.3M in option awards, accounting for 86% of the total pay in 2015.
Grint also received $250K in non-equity incentive plan, $446.5K in salary and $4K in other compensation.
Rankings
In 2015, Paul C. Grint's compensation ranked 1,590th out of 13,638 executives tracked by ExecPay. In other words, Grint earned more than 88.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,590 out of 13,638 | 88th |
Division Manufacturing | 575 out of 5,187 | 89th |
Major group Chemicals And Allied Products | 211 out of 1,857 | 89th |
Industry group Drugs | 162 out of 1,531 | 89th |
Industry Pharmaceutical Preparations | 130 out of 1,179 | 89th |
Source: SEC filing on April 28, 2017.
Grint's colleagues
We found three more compensation records of executives who worked with Paul C. Grint at Regulus Therapeutics in 2015.